The effect of PD-L1 categories-directed pembrolizumab plus chemotherapy for newly diagnosed metastatic non-small-cell lung cancer: a cost-effectiveness analysis
-
Published:2020-10
Issue:5
Volume:9
Page:1770-1784
-
ISSN:2218-6751
-
Container-title:Translational Lung Cancer Research
-
language:
-
Short-container-title:Transl Lung Cancer Res
Publisher
AME Publishing Company
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献